Publications by authors named "Barbara Pocali"

Claim this Profile
R
Real-life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy-cell leukemia: A multicenter Italian retrospective study (HCL-PG03R).
Luca De Carolis, Monia Capponi, Andrea Bernardelli, Andrea Visentin, Gianna Maria D'Elia, Barbara Pocali

Hemasphere· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real-world setting: Interim results of the Italian observational study (ROMEI).
Massimo Breccia, Francesca Palandri, Maurizio Martelli, Francesco Mendicino, Alessandra Malato, Barbara Pocali

Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.
Andrea Visentin, Thomas Chatzikonstantinou, Lydia Scarfò, Anargyros Kapetanakis, Christos Demosthenous, Barbara Pocali

Am J Hematol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.
Lydia Scarfò, Thomas Chatzikonstantinou, Gian Matteo Rigolin, Giulia Quaresmini, Marina Motta, Barbara Pocali

Leukemia· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vinorelbine plus intermediate dose cyclophosphamide is an effective and safe regimen for the mobilization of peripheral blood stem cells in patients with multiple myeloma.
Mario Annunziata, Maria Celentano, Barbara Pocali, Maria Rosaria D'Amico, Salvatore Palmieri

Ann Hematol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fludarabine and cytarabine as continuous sequential infusion for elderly patients with acute myeloid leukemia.
Felicetto Ferrara, Alfonso M D'Arco, Mariacarla De Simone, Giuseppina Mele, Catello Califano, Barbara Pocali

Haematologica· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose idarubicin and busulphan as conditioning to autologous stem cell transplantation in adult patients with acute myeloid leukaemia.
Felicetto Ferrara, Salvatore Palmieri, Mariacarla De Simone, Marco Sagristani, Assunta Viola, Barbara Pocali

Br J Haematol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outpatient-based peripheral blood stem cell transplantation for patients with multiple myeloma.
Felicetto Ferrara, Salvatore Palmieri, Assunta Viola, Carolina Copia, Ettore Mariano Schiavone, Barbara Pocali

Hematol J· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ifosfamide, epirubicin and etoposide (IEV) regimen as salvage and mobilization therapy for refractory or early relapsing patients with aggressive non-Hodgkin's lymphoma.
Barbara Pocali, Mariacarla De Simone, Mario Annunziata, Salvatore Palmieri, Maria Rosaria D'Amico

Leuk Lymphoma· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late relapse of acute promyelocytic leukemia treated with all- trans retinoic acid and chemotherapy: report of two cases.
Felicetto Ferrara, Carmine Selleri, Giuseppina Mele, Bianca Serio, Salvatore Palmieri, Barbara Pocali

Ann Hematol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged molecular remission after autologous stem cell transplantation in relapsed acute promyelocytic leukemia.
Felicetto Ferrara, Salvatore Palmieri, Mario Annunziata, Barbara Pocali, Assunta Viola

Haematologica· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy-related acute myeloid leukemia with t(9;11)(p12;q23) in a patient treated for acute promyelocytic leukemia.
Mario Annunziata, Salvatore Palmieri, Barbara Pocali, Mariacarla De Simone, Luigi Del Vecchio

Hematol J· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete remission induced by G-CSF in a patient with acute myeloid leukemia with t(8;21)(q22;q22).
Felicetto Ferrara, Ettore Mariano Schiavone, Salvatore Palmieri, Giuseppina Mele, Barbara Pocali

Hematol J· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fludarabine plus cyclophosphamide for the treatment of advanced chronic lymphocytic leukemia.
Ettore Mariano Schiavone, Mariacarla De Simone, Salvatore Palmieri, Mario Annunziata, Barbara Pocali

Eur J Haematol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macroamylasemia in a patient with multiple myeloma.
Marco Sagristani, Roberto Guariglia, Barbara Pocali, Mafalda De Rienzo, Salvatore Guastafierro

Leuk Lymphoma· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose cytarabine as consolidation treatment for patients with acute myeloid leukemia with t(8;21).
Salvatore Palmieri, Lucia Sebastio, Giuseppina Mele, Mario Annunziata, Silvana Annunziata, Barbara Pocali

Leuk Res· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De novo acute myeloid leukemia with multilineage dysplasia: treatment results and prognostic evaluation from a series of 44 patients treated with fludarabine, cytarabine and G-CSF (FLAG).
Felicetto Ferrara, Salvatore Palmieri, Barbara Pocali, Filiberto Pollio, Assunta Viola

Eur J Haematol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis